Sharp Physiotherapy Limited Filleted accounts for Companies House (small and micro)

COMPANY REGISTRATION NUMBER: 13829783

SHARP PHYSIOTHERAPY LIMITED

FILLETED UNAUDITED FINANCIAL STATEMENTS

31 January 2025

SHARP PHYSIOTHERAPY LIMITED

FINANCIAL STATEMENTS

YEAR ENDED 31 JANUARY 2025

CONTENTS	PAGE

Statement of financial position	1

Notes to the financial statements	3

SHARP PHYSIOTHERAPY LIMITED

STATEMENT OF FINANCIAL POSITION

31 January 2025

	2025		2024
Note	£	£	£

FIXED ASSETS

Tangible assets	6		25,686	3,076

CURRENT ASSETS

Debtors	7	–	85
Cash at bank and in hand		9,974	17,062
		--------	---------
		9,974	17,147

CREDITORS: amounts falling due within one year	8	9,237		10,458
		--------		---------
NET CURRENT ASSETS			737	6,689
			---------	--------
TOTAL ASSETS LESS CURRENT LIABILITIES			26,423	9,765

PROVISIONS	143	188
	---------	--------
NET ASSETS	26,280	9,577
	---------	--------

SHARP PHYSIOTHERAPY LIMITED

STATEMENT OF FINANCIAL POSITION (continued)

31 January 2025

	2025		2024
Note	£	£	£

CAPITAL AND RESERVES

Called up share capital	9	100	100
Profit and loss account		26,180	9,477
		---------	--------
SHAREHOLDERS FUNDS		26,280	9,577
		---------	--------

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.

In accordance with section 444 of the Companies Act 2006, the statement of income and retained earnings has not been delivered.

For the year ending 31 January 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;

- The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .

These financial statements were approved by the board of directors and authorised for issue on 27 October 2025 , and are signed on behalf of the board by:

Mrs F Sharp
Director

Company registration number: 13829783

SHARP PHYSIOTHERAPY LIMITED

NOTES TO THE FINANCIAL STATEMENTS

YEAR ENDED 31 JANUARY 2025

1. GENERAL INFORMATION

The company is a private company limited by shares, registered in England and Wales. The address of the registered office is Equitable House, 55 Pellon Lane, Halifax, West Yorkshire, HX1 5SP, England.

2. STATEMENT OF COMPLIANCE

These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.

3. ACCOUNTING POLICIES

Basis of preparation

The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.

The financial statements are prepared in sterling, which is the functional currency of the entity.

Judgements and key sources of estimation uncertainty

The preparation of the financial statements requires management to make judgements, estimates and assumptions that affect the amounts reported. These estimates and judgements are continually reviewed and are based on experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances. There are not considered to be any judgements or accounting estimates or assumptions that have a significant impact on the financial statements.

Revenue recognition

Turnover is measured at the fair value of the consideration received or receivable for goods supplied and services rendered, net of discounts and Value Added Tax. Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer (usually on despatch of the goods); the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably.

Current and deferred tax

The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case, tax is recognised in other comprehensive income or directly in equity, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.

Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.

Tangible assets

Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses. Any tangible assets carried at revalued amounts are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses. An increase in the carrying amount of an asset as a result of a revaluation, is recognised in other comprehensive income and accumulated in equity, except to the extent it reverses a revaluation decrease of the same asset previously recognised in profit or loss. A decrease in the carrying amount of an asset as a result of revaluation, is recognised in other comprehensive income to the extent of any previously recognised revaluation increase accumulated in equity in respect of that asset. Where a revaluation decrease exceeds the accumulated revaluation gains accumulated in equity in respect of that asset, the excess shall be recognised in profit or loss.

Depreciation

Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:

Leasehold alterations	-	10 years straight line
Fixtures, fittings and equipment	-	20% reducing balance

Provisions

Provisions are recognised when the entity has an obligation at the reporting date as a result of a past event, it is probable that the entity will be required to transfer economic benefits in settlement and the amount of the obligation can be estimated reliably. Provisions are recognised as a liability in the statement of financial position and the amount of the provision as an expense. Provisions are initially measured at the best estimate of the amount required to settle the obligation at the reporting date and subsequently reviewed at each reporting date and adjusted to reflect the current best estimate of the amount that would be required to settle the obligation. Any adjustments to the amounts previously recognised are recognised in profit or loss unless the provision was originally recognised as part of the cost of an asset. When a provision is measured at the present value of the amount expected to be required to settle the obligation, the unwinding of the discount is recognised as a finance cost in profit or loss in the period it arises.

Financial instruments

The company only has financial assets and financial liabilities of a kind that qualify as basic financial instruments. Basic financial instruments are initially recognised at transaction value and subsequently measured at their settlement value with the exception of bank loans which are subsequently measured at amortised cost using the effective interest method.

4. EMPLOYEE NUMBERS

The average number of persons employed by the company during the year amounted to 1 (2024: 1 ).

5. DIVIDENDS

	2025	2024
	£	£
Dividends paid during the year (excluding those for which a liability existed at the end of the prior year )	9,250	44,250
	--------	---------

6. TANGIBLE ASSETS

	Alterations to leasehold property	Fixtures, fittings and equipment	Total
	£	£	£
Cost
At 1 February 2024	–	4,145	4,145
Additions	24,884	–	24,884
	---------	--------	---------
At 31 January 2025	24,884	4,145	29,029
	---------	--------	---------
Depreciation
At 1 February 2024	–	1,069	1,069
Charge for the year	1,659	615	2,274
	---------	--------	---------
At 31 January 2025	1,659	1,684	3,343
	---------	--------	---------
Carrying amount
At 31 January 2025	23,225	2,461	25,686
	---------	--------	---------
At 31 January 2024	–	3,076	3,076
	---------	--------	---------

7. DEBTORS

	2025	2024
	£	£
Other debtors	–	85
	-----	-----

8. CREDITORS: amounts falling due within one year

	2025	2024
	£	£
Accruals and deferred income	2,410	1,867
Corporation tax	6,523	8,415
Social security and other taxes	69	–
Director loan accounts	235	176
	--------	---------
	9,237	10,458
	--------	---------

9. CALLED UP SHARE CAPITAL

Issued, called up and fully paid

	2025		2024
	No.	£	No.	£
Ordinary shares of £ 1 each	100	100	100	100
	-----	-----	-----	-----

10. DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

The directors loan account was in credit throughout the year. The loan is repayable on demand and no interest is charged.